Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on the development and commercialization of clinical-stage drug candidates, with exclusive worldwide commercial rights to three product candidates in clinical development for various central nervous system disorders.

Recs

0
Player Avatar Cab53RobertMsnG (63.69) Submitted: 5/27/2009 11:14:02 AM : Outperform Start Price: $13.23 VNDA Score: -114.50

VNDA

Featured Broker Partners


Advertisement